BioCentury | Jan 29, 2020
Company News

Decibel narrows discovery focus to inner ear regeneration, taps Reid as CEO

...inhibitors of LATS kinases. Reid, an entrepreneur-in-residence at Decibel's founding investor Third Rock Ventures, succeeds Steven Holtzman...
BioCentury | Oct 30, 2019
Company News

Management tracks: Vectura, Editas, Assembly, Camp4, Tempus, Passage Bio, Boundless Bio and Prometheus

...Camp4 Therapeutics Corp. , which has a machine learning-based platform to identify druggable targets, named Steven Holtzman...
BioCentury | Aug 22, 2019
Politics & Policy

Biomedical stakeholders caution against limiting U.S.-China collaboration

...China Ties" ). The stakeholders, led by Decibel Therapeutics Inc. (Boston, Mass.) President and CEO Steven Holtzman...
BioCentury | Aug 9, 2019
Tools & Techniques

The next frontier for single-cell analysis

...we aren’t just getting sequence information on garden variety cells,” said Decibel President and CEO Steven Holtzman...
BioCentury | Jun 22, 2018
Financial News

Decibel raises $55M in series C, names Scangos chairman

...NASDAQ:BIIB) from 2010 to 2016 and overlapped at the bellwether with Decibel President and CEO Steven Holtzman...
BioCentury | Jun 19, 2018
Financial News

Decibel raises $55M in series C, names Scangos chairman

...NASDAQ:BIIB) from 2010 to 2016 and overlapped at the bellwether with Decibel President and CEO Steven Holtzman...
BioCentury | May 31, 2018
Company News

Biogen names Karp to lead corporate development

...Bain Capital. He had led the biotech's business development activities since EVP of Corporate Development Steven Holtzman...
BioCentury | Dec 2, 2017
Strategy

Branching out

...prized our independence as much as we prized our independence,” said Decibel President and CEO Steven Holtzman...
...the biotech’s VelociSuite platform. “They prized our independence as much as we prized our independence.” Steven Holtzman...
BioCentury | Dec 1, 2017
Company News

Decibel, Regeneron enter hearing loss collaboration

...develop hearing loss and tinnitus therapies for up to seven years. Decibel President and CEO Steven Holtzman...
BioCentury | Nov 29, 2017
Company News

Decibel, Regeneron enter hearing loss collaboration

...develop hearing loss and tinnitus therapies for up to seven years. Decibel President and CEO Steven Holtzman...
Items per page:
1 - 10 of 81
BioCentury | Jan 29, 2020
Company News

Decibel narrows discovery focus to inner ear regeneration, taps Reid as CEO

...inhibitors of LATS kinases. Reid, an entrepreneur-in-residence at Decibel's founding investor Third Rock Ventures, succeeds Steven Holtzman...
BioCentury | Oct 30, 2019
Company News

Management tracks: Vectura, Editas, Assembly, Camp4, Tempus, Passage Bio, Boundless Bio and Prometheus

...Camp4 Therapeutics Corp. , which has a machine learning-based platform to identify druggable targets, named Steven Holtzman...
BioCentury | Aug 22, 2019
Politics & Policy

Biomedical stakeholders caution against limiting U.S.-China collaboration

...China Ties" ). The stakeholders, led by Decibel Therapeutics Inc. (Boston, Mass.) President and CEO Steven Holtzman...
BioCentury | Aug 9, 2019
Tools & Techniques

The next frontier for single-cell analysis

...we aren’t just getting sequence information on garden variety cells,” said Decibel President and CEO Steven Holtzman...
BioCentury | Jun 22, 2018
Financial News

Decibel raises $55M in series C, names Scangos chairman

...NASDAQ:BIIB) from 2010 to 2016 and overlapped at the bellwether with Decibel President and CEO Steven Holtzman...
BioCentury | Jun 19, 2018
Financial News

Decibel raises $55M in series C, names Scangos chairman

...NASDAQ:BIIB) from 2010 to 2016 and overlapped at the bellwether with Decibel President and CEO Steven Holtzman...
BioCentury | May 31, 2018
Company News

Biogen names Karp to lead corporate development

...Bain Capital. He had led the biotech's business development activities since EVP of Corporate Development Steven Holtzman...
BioCentury | Dec 2, 2017
Strategy

Branching out

...prized our independence as much as we prized our independence,” said Decibel President and CEO Steven Holtzman...
...the biotech’s VelociSuite platform. “They prized our independence as much as we prized our independence.” Steven Holtzman...
BioCentury | Dec 1, 2017
Company News

Decibel, Regeneron enter hearing loss collaboration

...develop hearing loss and tinnitus therapies for up to seven years. Decibel President and CEO Steven Holtzman...
BioCentury | Nov 29, 2017
Company News

Decibel, Regeneron enter hearing loss collaboration

...develop hearing loss and tinnitus therapies for up to seven years. Decibel President and CEO Steven Holtzman...
Items per page:
1 - 10 of 81